Feng Chi Biotech (ROCO:6744) Total Assets : NT$301.0 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Feng Chi Biotech Total Assets?

Feng Chi Biotech's Total Assets for the quarter that ended in Dec. 2023 was NT$301.0 Mil.

During the past 12 months, Feng Chi Biotech's average Total Assets Growth Rate was 16.00% per year. During the past 3 years, the average Total Assets Growth Rate was 9.60% per year. During the past 5 years, the average Total Assets Growth Rate was 2.70% per year.

During the past 8 years, Feng Chi Biotech's highest 3-Year average Total Assets Growth Rate was 9.60%. The lowest was -18.20%. And the median was 2.40%.

Total Assets is connected with ROA %. Feng Chi Biotech's annualized ROA % for the quarter that ended in Dec. 2023 was 6.20%. Total Assets is also linked to Revenue through Asset Turnover. Feng Chi Biotech's Asset Turnover for the quarter that ended in Dec. 2023 was 0.28.

Feng Chi Biotech Total Assets Historical Data

The historical data trend for Feng Chi Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feng Chi Biotech Total Assets Chart

Feng Chi Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

267.32

283.99

286.69

308.36

301.03

Feng Chi Biotech Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial									286.69	295.71	308.36	311.31	301.03

Feng Chi Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Feng Chi Biotech's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	237.998	+	63.034
	=	301.0

Feng Chi Biotech's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	237.998	+	63.034
	=	301.0

Feng Chi Biotech (ROCO:6744) Total Assets Explanation

Total Assets is connected with ROA %.

Feng Chi Biotech's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	18.976	/	( (311.313	+	301.032)	/ 2 )
	=	18.976	/	306.1725
	=	6.20 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Feng Chi Biotech's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	86.225	/	( (311.313	+	301.032)	/ 2 )
=	86.225	/	306.1725
=	0.28

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Feng Chi Biotech Total Assets Related Terms

Thank you for viewing the detailed overview of Feng Chi Biotech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Feng Chi Biotech (ROCO:6744) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Feng Chi Biotech Corp (ROCO:6744) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100

Website

http://www.fcbiotech.com.tw

Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.

Feng Chi Biotech (ROCO:6744) Headlines

No Headlines